论文部分内容阅读
原发性血小板减少性紫癜,是较多见的一种血液病,治疗方法繁多,但迄今无特效疗法.我院门诊于1978～1979年试用上海十二制药厂合成的梯洛龙(Tilorone)治疗原发性血小板减少性紫癜9例及继发性血小板减少者2例,兹小结如下: 一、一般资料本组11例中,男4例,女7例;年龄
Primary thrombocytopenic purpura, is a more common form of blood disease, the treatment of a wide range, but so far no effective treatment.Our hospital in 1978 to 1979 trial of Shanghai Twelve pharmaceutical synthesis of Ladlor (Tilorone) Treatment of primary thrombocytopenic purpura in 9 cases and 2 cases of secondary thrombocytopenia, are summarized as follows: First, the general information in this group of 11 patients, 4 males and 7 females; age